“…Diverse mechanisms of resistance of these organisms limit the available therapeutic agents, make the infection difficult to treat, and are associated with a greater risk of death [41]. In the emerging scenario of concomitant problems and diseases [42][43][44][45][46][47][48][49][50][51][52][53][54][55][56],intensivists should be familiar with available drugs, environmental epidemiology and patient factors [40,53] as well as with new emerging findings regard use of cardiovascular drugs [42][43][47][48][51][52]. We present a case of an infective endocarditis in a 69-year-old Italian woman.…”